Philip A. Pizzo, Director at Global Blood Therapeutics, Inc. (GBT), sold 1,065 shares at $36.54 ($39K) on 2021-06-18, disclosed to the SEC on 2021-06-21.
Scheduled sale ($39k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |